Endocrinology Medical News about Saxagliptin

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes on Metformin Alone
Diabetes Care, 06/01/09

DeFronzo RA et al. - Saxagliptin once daily added to metformin therapy was generally well tolerated and led to statistically significant improvements in glycemic indices vs. placebo added to metformin in patients with type 2 diabetes inadequately controlled on metformin alone.

<< Previous
Aspirin for cardiovascular prevention in patients with diabetes

Next >>
Gemcitabine and oxaliplatin combination chemotherapy for...

Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone
Journal of Clinical Endocrinology and Metabolism, 11/10/09 Relevance Score: 87%

Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes
Current Medical Research and Opinion, 10/02/09 Relevance Score: 84%

ONGLYZA (saxagliptin) Receives Marketing Authorisation In Europe For The Treatment Of Type 2 Diabetes
Bristol Myers-Squibb Company, 10/06/09 Relevance Score: 80%

Study Finds That ONGLYZA (saxagliptin) When Added To Metformin Was Non-Inferior To JANUVIA When Added To Metformin In Reducing Hemoglobin In Adults With Type 2 Diabetes Mellitus
Bristol Myers-Squibb Company, 10/06/09 Relevance Score: 80%